Search Count: 9
 |
Dissecting Human Monoclonal Antibody Responses From Mrna And Protein-Based Booster Vaccinations Against Xbb1.5 Sars-Cov-2
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-03-12 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Dissecting Human Monoclonal Antibody Responses From Mrna And Protein-Based Booster Vaccinations Against Xbb1.5 Sars-Cov-2
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-03-12 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Protective Effect Of Human Non-Neutralizing Cross-Reactive Spike Antibodies Elicited By Sars-Cov-2 Mrna Vaccination
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-10-23 Classification: IMMUNE SYSTEM Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Method: ELECTRON MICROSCOPY Resolution:3.00 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG, ACT |
 |
Organism: Lama glama, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG, CIT, CL |
 |
Organism: Lama glama, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG, CIT, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG, GOL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Lama glama
Method: X-RAY DIFFRACTION Resolution:2.34 Å Release Date: 2021-08-11 Classification: ANTIVIRAL PROTEIN Ligands: NAG |